Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 7—July 2009
Dispatch

Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel

Shmuel Stienlauf1Comments to Author , Vered Yahalom1, Eli Schwartz, Eilat Shinar, Gad Segal, and Yechezkel Sidi
Author affiliations: Sheba Medical Center, Tel Hashomer, Israel (S. Stienlauf, E. Schwartz, G. Segal, Y. Sidi); Tel Aviv University, Tel Aviv, Israel (S. Stienlauf, E. Schwartz, G. Segal, Y. Sidi); Magen David Adom National Blood Services, Ramat Gan, Israel (V. Yahalom, E. Shinar).; 1These authors contributed equally to this article.

Main Article

Table

Prevalence of HTLV-1 in blood donors from different countries of origin, Israel, 1995–1998*

Country No. HTLV-1 carriers No. blood bank donors No. carriers/ 100,000 donors
Iran 16 31,776 50.4
Romania 12 73,971 14.9
Iraq 7 68,857 10.2
Russian Federation 7 111,109 6.3
Turkey 4 25,054 16
Poland 3 70,172 4.3
Israel 3 294,342 1.0
Morocco 3 144,014 2.1
United States 3 49,204 6.1
Yugoslavia† 2 3,181 62.9
Uruguay 2 3,552 56.3
Argentina 2 20,898 9.6
Chile 2 2,101 95.2
Czechoslovakia† 1 11,149 9.0
Brazil 1 4,217 23.7
Niger 1 1
Ethiopia 1 3,412 29.3
Egypt 1 21,245 4.7
Yemen 1 36,052 2.8
Libya 1 21,427 4.7

*HTLV-1, human T-lymphotropic virus type 1.
†Country no longer exists.

Main Article

1These authors contributed equally to this article.

Page created: September 14, 2012
Page updated: September 14, 2012
Page reviewed: September 14, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external